ICH Sets Three-Year Goal To Harmonize Criteria For Biowaivers
Executive Summary
ICH outlines an ambitious work plan to harmonize the disparate requirements for biowaivers among regulators worldwide; New concept paper and business plan highlight areas of disagreement.
You may also be interested in...
ICH Consults On Harmonized Criteria For Bioequivalence Study Waivers
The International Council for Harmonisation has issued draft guidance specifying the supportive data needed to classify a drug substance under the Biopharmaceutics Classification System and for biowaiver applications.
ICH Consults On Harmonized Criteria For Bioequivalence Study Waivers
The International Council for Harmonisation has issued draft guidance specifying the supportive data needed to classify a drug substance under the Biopharmaceutics Classification System and for biowaiver applications.
Quality Regulatory Updates In Brief: ICH, EMA, MHRA and FDA
ICH updates progress made on quality guidelines; EMA talks combination products; UK MHRA report sheds light on GMP deficiencies; MHRA official describes compliance escalation; FDA guides microbiology reviewers through Common Technical Document; FDA OKs reliance on non-USP compendia in applications.